Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes

Journal of Controlled Release

Volumn 133, Issue 3, 2009, Pages 214-220

  Geusens, B ^a   Lambert, J ^a   De Smedt, S C ^b   Buyens, K ^b   Sanders, N N ^b   Van Gele, M ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Delivery vehicle; Melanocytes; siRNA; Skin; Ultradeformable liposomes

Indexed keywords

DYES; NUCLEIC ACIDS; PHOSPHOLIPIDS; PROPANE; RNA; SKIN;

DELIVERY VEHICLE; IN-VIVO; ISOFORM; MELANOCYTES; MYOSIN VA; SIRNA; TRANSFECTION EFFICIENCY; ULTRADEFORMABLE LIPOSOMES;

LIPOSOMES;

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CHOLIC ACID; LIPOSOME; SMALL INTERFERING RNA;

ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; EXON; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MELANOCYTE; MELANOSOME; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE CHARGE;

CATIONS; CELL SURVIVAL; CELLS, CULTURED; CRYOELECTRON MICROSCOPY; DRUG STABILITY; ELECTRICITY; FATTY ACIDS, MONOUNSATURATED; GENE EXPRESSION; HUMANS; INFANT, NEWBORN; LIPOSOMES; MALE; MELANOCYTES; MICROPORE FILTERS; MYOSIN HEAVY CHAINS; MYOSIN TYPE V; PARTICLE SIZE; QUATERNARY AMMONIUM COMPOUNDS; RNA INTERFERENCE; RNA, SMALL INTERFERING; SODIUM CHOLATE; TRANSFECTION;

EID: 58549109865     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.10.003     Document Type: Article

References (49)

1. Barry B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14 (2001) 101-114
2. Bouwstra J.A., and Honeywell-Nguyen P.L. Skin structure and mode of action of vesicles. Adv. Drug Deliv. Rev. 54 Suppl 1 (2002) S41-S55
3. Barry B.W. Dermatological Formulations: Percutaneous Absorption (1983), Dekker, New York
4. Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carr. Syst. 13 (1996) 257-388
5. Cevc G., Gebauer D., Stieber J., Schatzlein A., and Blume G. Ultraflexible vesicles, Transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368 (1998) 201-215
6. Schatzlein A., and Cevc G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br. J. Dermatol. 138 (1998) 583-592
7. Cevc G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin. Pharmacokinet. 42 (2003) 461-474
8. Cevc G., and Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104 (1992) 226-232
9. Cevc G., and Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta 1514 (2001) 191-205
10. Cevc G., and Blume G. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes. Biochim. Biophys. Acta 1614 (2003) 156-164
11. Cevc G., and Blume G. Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect, and reduced therapeutic dosage. Biochim. Biophys. Acta 1663 (2004) 61-73
12. Fesq H., Lehmann J., Kontny A., Erdmann I., Theiling K., Rother M., Ring J., Cevc G., and Abeck D. Improved risk-benefit ratio for topical triamcinolone acetonide in Transfersome in comparison with equipotent cream and ointment: a randomized controlled trial. Br. J. Dermatol. 149 (2003) 611-619
13. Garg M., Mishra D., Agashe H., and Jain N.K. Ethinylestradiol-loaded ultraflexible liposomes: pharmacokinetics and pharmacodynamics. J. Pharm. Pharmacol. 58 (2006) 459-468
14. Guo J., Ping Q., Sun G., and Jiao C. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int. J. Pharm. 194 (2000) 201-207
15. Guo J., Ping Q., and Zhang L. Transdermal delivery of insulin in mice by using lecithin vesicles as a carrier. Drug Deliv. 7 (2000) 113-116
16. Jain S., Sapre R., Tiwary A.K., and Jain N.K. Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development, characterization, and performance evaluation. AAPS PharmSci Tech 6 (2005) E513-E522
17. Jain S., Tiwary A.K., and Jain N.K. Sustained and targeted delivery of an anti-HIV agent using elastic liposomal formulation: mechanism of action. Curr. Drug Deliv. 3 (2006) 157-166
18. Paul A., Cevc G., and Bachhawat B.K. Transdermal immunization with large proteins by means of ultradeformable drug carriers. Eur. J. Immunol. 25 (1995) 3521-3524
19. Paul A., Cevc G., and Bachhawat B.K. Transdermal immunisation with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfersomes. Vaccine 16 (1998) 188-195
20. Planas M.E., Gonzalez P., Rodriguez L., Sanchez S., and Cevc G. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier, and prolongation of local pain insensitivity by anesthetic liposomes. Anesth. Analg. 75 (1992) 615-621
21. Song Y.K., and Kim C.K. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 27 (2006) 271-280
22. Alexander M.Y., and Akhurst R.J. Liposome-medicated gene transfer and expression via the skin. Hum. Mol. Genet. 4 (1995) 2279-2285
23. Babiuk S., Baca-Estrada M.E., Pontarollo R., and Foldvari M. Topical delivery of plasmid DNA using biphasic lipid vesicles (Biphasix). J. Pharm. Pharmacol. 54 (2002) 1609-1614
24. Birchall J.C., Marichal C., Campbell L., Alwan A., Hadgraft J., and Gumbleton M. Gene expression in an intact ex-vivo skin tissue model following percutaneous delivery of cationic liposome-plasmid DNA complexes. Int. J. Pharm. 197 (2000) 233-238
25. Cui Z., and Mumper R.J. Topical immunization using nanoengineered genetic vaccines. J. Control. Release 81 (2002) 173-184
26. Kim A., Lee E.H., Choi S.H., and Kim C.K. In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials 25 (2004) 305-313
27. Lee E.H., Kim A., Oh Y.K., and Kim C.K. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials 26 (2005) 205-210
28. Niemiec S.M., Latta J.M., Ramachandran C., Weiner N.D., and Roessler B.J. Perifollicular transgenic expression of human interleukin-1 receptor antagonist protein following topical application of novel liposome-plasmid DNA formulations in vivo. J. Pharm. Sci. 86 (1997) 701-708
29. Shi Z., Curiel D.T., and Tang D.C. DNA-based non-invasive vaccination onto the skin. Vaccine 17 (1999) 2136-2141
30. Watabe S., Xin K.Q., Ihata A., Liu L.J., Honsho A., Aoki I., Hamajima K., Wahren B., and Okuda K. Protection against influenza virus challenge by topical application of influenza DNA vaccine. Vaccine 19 (2001) 4434-4444
31. Aigner A. Nonviral in vivo delivery of therapeutic small interfering RNAs. Curr. Opin. Mol. Ther. 9 (2007) 345-352
32. Zhang S., Zhao B., Jiang H., Wang B., and Ma B. Cationic lipids and polymers mediated vectors for delivery of siRNA. J. Control. Release 123 (2007) 1-10
33. Dykxhoorn D.M., and Lieberman J. Knocking down disease with siRNAs. Cell 126 (2006) 231-235
34. Ma Z., Li J., He F., Wilson A., Pitt B., and Li S. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem. Biophys. Res. Commun. 330 (2005) 755-759
35. Sioud M., and Søensen D.R. Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem. Biohys. Res. Commun. 312 (2003) 1220-1225
36. Sorensen D.R., Leirdal M., and Sioud M. Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327 (2003) 761-766
37. Van Gele M., Geusens B., Schmitt A.M., Aguilar L., and Lambert J. Knockdown of myosin Va isoforms by RNAi as a tool to block melanosome transport in primary human melanocytes. J. Invest. Dermatol. 128 (2008) 2474-2484
38. Trotta M., Peira E., Debernardi F., and Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int. J. Pharm. 241 (2002) 319-327
39. Dubochet J., Adrian M., Chang J.J., Homo J.C., Lepault J., McDowall A.W., and Schultz P. Cryo-electron microscopy of vitrified specimens. Q. Rev. Biophys. 21 (1988) 129-228
40. Frederik P.M., Stuart M.C., Bomans P.H., and Busing W.M. Phospholipid, nature's own slide and cover slip for cryo-electron microscopy. J. Microsc. 153 (1989) 81-92
41. Naeyaert J.M., Eller M., Gordon P.R., Park H.Y., and Gilchrest B.A. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. Br. J. Dermatol. 125 (1991) 297-303
42. Crouch S.P., Kozlowski R., Slater K.J., and Fletcher J. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J. Immunol. Methods 160 (1993) 81-88
43. Zuidam N.J., Hirsch-Lerner D., Margulies S., and Barenholz Y. Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency. Biochim. Biophys. Acta 1419 (1999) 207-220
44. Judge A.D., Sood V., Shaw J.R., Fang D., McClintock K., and MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat. Biotechnol. 23 (2005) 457-462
45. Muhonen P., Avnet S., Parthasarathy R.N., Janckila A.J., Halleen J.M., Laitala-Leinonen T., and Vaananen H.K. Sequence and TLR9 independent increase of TRACP expression by antisense DNA and siRNA molecules. Biochem. Biophys. Res. Commun. 359 (2007) 889-895
46. Haley B., and Zamore P.D. Kinetic analysis of the RNAi enzyme complex. Nat. Struct. Mol. Biol. 11 (2004) 599-606
47. Vorauer-Uhl K., Wagner A., and Katinger H. Long term stability of rh-Cu/Zn-superoxide dismutase (SOD)-liposomes prepared by the cross-flow injection technique following International Conference on Harmonisation (ICH)-guidelines. Eur. J. Pharm. Biopharm. 54 (2002) 83-87
48. Dubey V., Mishra D., Dutta T., Nahar M., Saraf D.K., and Jain N.K. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control. Release 123 (2007) 148-154
49. Kibat P.G., and Stricker H. Storage stability of dispersions of soybean lecithin liposomes (part 3). Pharm. Ind. 48 (1986) 1184-1189